Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject Drugs

Abstract

Hepatitis C viral infection (HCV) has become a curable disease due to the development of direct acting antivirals (DAA). Therefore, the World Health Organization (WHO) has set a target to eliminate HCV. The largest group at risk for HCV at present are people who inject drugs (PWID), especially in the western world. Due to various barriers, this risk group is still underserved for HCV. Our goal was to study if a case management policy of a known PWID cohort could improve uptake for screening and treatment.